NM_001368397.1:c.2182G>C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001368397.1(FRMPD4):c.2182G>C(p.Ala728Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,207,979 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001368397.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRMPD4 | NM_001368397.1 | c.2182G>C | p.Ala728Pro | missense_variant | Exon 15 of 17 | ENST00000675598.1 | NP_001355326.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRMPD4 | ENST00000675598.1 | c.2182G>C | p.Ala728Pro | missense_variant | Exon 15 of 17 | NM_001368397.1 | ENSP00000502607.1 |
Frequencies
GnomAD3 genomes AF: 0.00000896 AC: 1AN: 111659Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33829
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183415Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67847
GnomAD4 exome AF: 0.0000119 AC: 13AN: 1096320Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 5AN XY: 361708
GnomAD4 genome AF: 0.00000896 AC: 1AN: 111659Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33829
ClinVar
Submissions by phenotype
Intellectual disability, X-linked 104 Uncertain:2
The missense variant p.Ala728Pro in FRMPD4 has been submitted to ClinVar as a Variant of Uncertain Significance, but no details are available for independent assessment. The p.Ala728Pro variant is novel (not in any individuals) in 1000 Genomes and has allele frequency of 0.001462% in gnomAD database. The amino acid Ala at position 728 is changed to a Pro changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Ala728Pro in FRMPD4 is predicted as conserved by PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance (VUS) -
Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as 3C-VUS. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0109 - This gene is known to be associated with X-linked FRMPD4-related intellectual disability. (N) 0200 - Variant is predicted to result in a missense amino acid change from an alanine to a proline (exon 15). (N) 0253 - Variant is hemizygous. (N) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (3 heterozygotes, 0 hemizygotes). (P) 0309 - Multiple alternative amino acid changes at the same position have been observed in gnomAD (highest allele count: 19 heterozygotes, 5 hemizygotes). (N) 0503 - Missense variant consistently predicted to be tolerated and not conserved in mammals with a minor amino acid change. (B) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (N) 0705 - A comparable variant has previously been classified as a VUS in ClinVar. (N) 0807 - Variant has not previously been reported in a clinical context. (N) 0905 - No segregation evidence has been identified for this variant. (N) 1007 - No published functional evidence has been identified for this variant in the literature. (N) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign -
Inborn genetic diseases Uncertain:1
The alteration results in an amino acid change:_x000D_ _x000D_ The c.2182G>C (p.A728P) alteration is located in coding exon 15 of the FRMPD4 gene. This alteration results from a G to C substitution at nucleotide position 2182, causing the alanine (A) at amino acid position 728 to be replaced by a proline (P). The alteration has been observed in population databases: _x000D_ _x000D_ Based on data from the Genome Aggregation Database (gnomAD), the c.2182G>C alteration was observed in 0.0015%% (3/205,162) of total alleles studied. No hemizygotes were reported in gnomAD. The altered amino acid is not conserved throughout evolution:_x000D_ _x000D_ The p.A728 amino acid is not conserved in available vertebrate species. The alteration is predicted tolerated by in silico modeling:_x000D_ _x000D_ The p.A728P alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at